Application Notes & Case Studies

  1. FDA Fast-Tracked Clinical Trial 7/9/2026

    Deconstruct the enrollment bottleneck in an ophthalmic gene therapy trial, discovering how point-of-need pre-screening cuts site activation delays and accelerates clinical development timelines.

  2. Transforming Ophthalmic Assessments For A Mid-Trial Protocol Change 7/9/2026

    Discover how a biopharmaceutical company integrated urgent mid-trial mandates across 65 sites, cutting standard onboarding timelines in half while preserving critical enrollment milestones.

  3. Reserving Data Integrity With Retrospective Manual Entry 7/5/2026

    A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.

  4. Maintain Compliance Through Divestiture Without Disrupting Operations 6/25/2026

    Facing a divestiture? Learn how to protect historical quality records and stay audit-ready throughout the transition. 

  5. DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS 6/18/2026

    How does the DECODE CRS Coalition help trial sponsors standardize protocols and build a first-of-its-kind wearable dataset to lower development costs and safely de-risk outpatient care?

  6. A Mission To Expand Recruitment Territory 6/11/2026

    Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.

  7. Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies 6/5/2026

    See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.

  8. Successful SwissMedic Marketing Authorization Application For An Oncology Therapy 6/4/2026

    See how strategic EU dossier adaptation and Swiss-specific regulatory expertise enabled a successful SwissMedic submission and accelerated market access for an oncology therapy.

  9. End-To-End Clinical, Biometrics, And Regulatory Support In Neurology 6/4/2026

    Discover how an integrated NDA strategy aligned data, vendors, and regulatory execution to achieve an on-time submission and approval without major FDA queries.

  10. Building A Scalable Oncology Engine In A Dynamic Market 6/3/2026

    Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.